As a key executive leader and member of the Board, provide strategic vision and leadership to drive global regulatory strategies, commercial excellence, and operational growth. Oversee critical functions, including legal, intellectual property, business development, and new ventures, ensuring the organization is positioned for long-term success. Lead corporate and business development initiatives, including negotiating significant contracts, forming strategic partnerships, and securing financing agreements, while spearheading advocacy efforts and external engagements to elevate the company’s reputation and influence—particularly in rare disease markets.Collaborate closely with clinical development teams to align pipeline strategies with corporate objectives, ensuring seamless integration of R&D and commercialization efforts. Leverage a deep understanding of market dynamics, competitive intelligence, and emerging trends to champion innovation and identify new commercial opportunities. Guide the organization in navigating complex regulatory landscapes, enabling efficient product development, approval, and market access for life-changing therapies.With a focus on financial acumen and capital raising, support investor relations (IR) and public relations (PR) efforts, including fundraising activities, to secure resources necessary for sustained growth. Build and maintain a robust network of stakeholders, including investors, regulators, and industry leaders, to drive strategic alliances and ensure alignment with the company’s mission.In this multifaceted role, serve as a catalyst for organizational growth and transformation by combining strategic foresight, operational excellence, and stakeholder engagement. Deliver life-changing therapies to patients with high unmet needs, ensuring the company thrives in an evolving and competitive pharmaceutical landscape.

Developed and executed global strategies for market access, trade, pricing, reimbursement, and distribution to ensure the successful commercialization of innovative therapies. Led efforts to navigate complex regulatory and payer environments, enabling patients worldwide to access life-changing treatments.Spearheaded initiatives to bring to market the first approved treatment option for patients with Single Ventricular Heart Disease who had undergone the Fontan operation. Crafted innovative access strategies and engaged with key stakeholders to overcome barriers and secure reimbursement pathways, ultimately transforming care for this underserved patient population.In this role, aligned commercial objectives, patient needs, and healthcare system requirements to deliver sustainable value across global markets.

Developed and implemented access strategies, innovation initiatives, and value-based solutions focused on reducing costs and improving patient outcomes. Directed a cross-functional team responsible for driving $4.8 billion in revenue, ensuring alignment with organizational goals and market demands.Collaborated across diverse departments, including marketing, contracting, payer sales, specialty, analytics, medical, health economics, digital health, innovation, legal, and regulatory, to accelerate execution and achieve optimized results. Partnered with technology leaders to enhance the identification, diagnosis, and treatment of rare diseases and specialty conditions, leveraging cutting-edge solutions to expand access and improve care delivery.

Led a team of 100+ employees in the South Florida and Puerto Rico region, driving $400 million annually in revenue across respiratory, diabetes, and cardiovascular portfolios. Oversaw hiring, leadership development, and the creation of regional business plans rooted in customer insights, resource allocation, and strategic prioritization.Built and maintained strong relationships with top HMOs, IDNs, health systems, and medical groups throughout Florida and Puerto Rico, engaging directly or through Business Managers and Specialists to ensure alignment with organizational objectives and customer needs.Recognized for exceptional performance with numerous accolades, including the Senior Leadership Award (top 5% globally), two HIRC "Best-in-Class" awards, President's Club for Performing While Transforming (top 5%), as well as Silver (top 15%) and Bronze (top 20%) honors.

Designed and implemented a groundbreaking commercial model for BI in Florida, focused on delivering advanced knowledge, insights, and strategies to optimize market access and enhance the company's value proposition. Engaged top healthcare systems, including IDNs, PBMs, health plans, medical groups, ACOs, and hospitals, to drive meaningful partnerships and achieve strategic goals. Collaborated with national accounts such as Humana, UnitedHealthcare, Cigna, Anthem, Catamaran, and WellCare, surpassing revenue targets by 296% and generating an incremental $79.1M in revenue within two years.Pioneered BI's first risk-based contract, achieving +40% prescription growth and a -14.5% reduction in AFib PMPM costs in one year. Managed a revenue portfolio exceeding $300M annually, leading a team of over 150 people. Championed innovative contracting strategies, transforming regional account revenue from $2M in 2011 to over $40M annually by 2014.Recognized for exceptional contributions with numerous awards, including the Outstanding Sales Achievement Award (5th President’s Club), President’s Club (4x), Team Innovation Awards (3x), and "Best-in-Class Pharmacy Executive" honors from HSG/HIRC (2x). Selected for BI's Leadership Development Program, completing with "exceeds expectations" distinction.

Recognized as a consultative and innovative expert in emerging trends and customer engagement channels. Directed the end-to-end discovery, design, development, and execution of an outsourced virtual sales contact center, which became the second-largest in the U.S. pharmaceutical industry. Oversaw a multi-channel team to ensure effective training, ROI delivery, data capture and integration, and capacity planning to maximize operational efficiency and impact.Co-led Healthcare IT initiatives, driving the creation and management of national partnerships with EHR and PHR vendors. Conducted comprehensive market research and spearheaded the development and roll-out of a national strategy and tactical implementation, ensuring alignment with evolving industry needs and customer demands. Demonstrated leadership in leveraging digital innovations to enhance engagement, streamline operations, and deliver measurable business results.

Served as an internal leader and expert, co-developing and executing comprehensive Healthcare IT strategies and tactics across the organization. Spearheaded the implementation and national roll-out of a Medicaid pull-through program, achieving a 20% increase in market share.Independently conducted primary research to identify opportunities for enhancing training programs, optimizing operational efficiencies, and fostering cross-functional collaboration. Delivered strategic insights and innovative solutions to drive market success and improve organizational performance.

Oversaw the operations of over 1,000 promotional projects across five brand teams in the cardiovascular, urology, and HIV therapeutic areas. Streamlined the medical, legal, and regulatory approval processes, reducing production timelines for promotional resources by 30 days to enhance efficiency and speed to market.Provided strategic guidance and education to brand teams on executing multi-cultural campaigns, digital media strategies, direct-to-consumer (DTC) initiatives, and relationship marketing programs. Ensured alignment with brand objectives while driving innovation and operational excellence in marketing execution.

Co-led scenario planning for a Phase III brand, collaborating with a cross-functional extended team of over 40 members to guide strategic decision-making. Delivered actionable competitive intelligence, including analysis of outcomes and implications, to inform and enhance marketing strategies.Facilitated data collection and insights generation at national conferences and advisory boards, ensuring alignment with business objectives and market dynamics. Played a critical role in integrating analytics into strategic planning to support brand success and competitive positioning.

Delivered exceptional sales performance across multiple therapeutic areas, including cardiovascular (CV), urology, HIV, COPD, stroke, hypertension, Parkinson’s disease, and arthritis. Cultivated strong relationships with healthcare professionals in institutional, specialty, and primary care settings to drive product adoption and exceed sales targets.As an Institutional Specialty Sales Representative (2005-2007), specialized in engaging academic and federal hospitals and healthcare systems, focusing on complex therapies to meet the needs of specialized patient populations.As a Specialty Sales Representative (2004-2005), managed targeted providers and accounts to promote advanced therapeutic solutions and educate healthcare providers on innovative treatment options.As a Primary Care Sales Representative (2003-2004), built foundational expertise in promoting a broad portfolio of products to primary care physicians, fostering trust and driving growth in competitive markets.

Developed, validated, and automated innovative assays to support diabetes drug discovery efforts. Leveraged scientific expertise to enhance the pre-clinical pipeline by optimizing assay performance and ensuring robust, reproducible results. Contributed to the identification and evaluation of potential therapeutic candidates, advancing the discovery and development of novel diabetes treatments.

Supported investigators in conducting in vivo experiments to gather critical preliminary data on efficacy, toxicity, and pharmacokinetics. Played a key role in experimental setup, data collection, and analysis to advance preclinical research and inform subsequent phases of investigation. Ensured adherence to laboratory protocols and contributed to the generation of reliable and reproducible results to support scientific discoveries.